Corporate Background

Sengenics is a functional proteomics and research and diagnostics company, with a
range of proprietary and patented technologies and products.
The main focus of the company is leveraging on our core patented Immunome
protein array technology for discovering antibody-based therapeutics and
diagnostic signatures for immune system disorders. The Immunome protein array
platform was originally developed as a collaboration between the University of
Oxford and the University of Cambridge, by Professor Jonathan Blackburn.